{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T17:25:47Z","timestamp":1778433947577,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jcjd.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T13:13:24Z","timestamp":1544706804000},"page":"322-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of Healthy User Effects With Metformin and Other Oral Antihyperglycemia Medication Users in Adult Patients With Type 2 Diabetes"],"prefix":"10.1016","volume":"43","author":[{"given":"Maxim","family":"Eskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scot H.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean Trevor","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2018.12.001_bib1","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","article-title":"Statin adherence and risk of accidents: A\u00a0cautionary tale","volume":"119","author":"Dormuth","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcjd.2018.12.001_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11606-011-1939-7","article-title":"Statins and sepsis: Scientifically interesting but clinically inconsequential","volume":"27","author":"Eurich","year":"2012","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jcjd.2018.12.001_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.38992.565972.7C","article-title":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: Population based prospective cohort study","volume":"333","author":"Majumdar","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2018.12.001_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/pds.4112","article-title":"The effect of statins on influenza-like illness: Morbidity and mortality","volume":"26","author":"Brassard","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jcjd.2018.12.001_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwm070","article-title":"Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect","volume":"166","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcjd.2018.12.001_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.200802-282OC","article-title":"Mortality reduction with influenza vaccine in patients with pneumonia outside flu season: Pleiotropic benefits or residual confounding?","volume":"178","author":"Eurich","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcjd.2018.12.001_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jval.2010.10.033","article-title":"The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jcjd.2018.12.001_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jcjd.2018.12.001_bib9","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMp058267","article-title":"Observational studies of drugs and mortality","volume":"353","author":"Ray","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcjd.2018.12.001_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/humrep\/deh022","article-title":"Hormone replacement therapy and acute coronary outcomes: Methodological issues between randomized and observational studies","volume":"19","author":"Garbe","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jcjd.2018.12.001_bib11","first-page":"135","article-title":"Debate: The potential role of estrogen in the prevention of heart disease in women after menopause","volume":"1","author":"Rossouw","year":"2000","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.jcjd.2018.12.001_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.294.1.56","article-title":"Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women\u2019s Health Study: A randomized controlled trial","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2018.12.001_bib13","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: A meta-analysis of randomized controlled trials","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.jcjd.2018.12.001_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/bmj.39314.620174.80","article-title":"Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: Systematic review","volume":"335","author":"Eurich","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2018.12.001_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/ACPJC-2017-166-8-046","article-title":"Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF","volume":"166","author":"Jasim","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcjd.2018.12.001_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2018.12.001_bib17","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/diacare.25.12.2244","article-title":"Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes","volume":"25","author":"Johnson","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2018.12.001_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1464-5491.2005.01448.x","article-title":"Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes","volume":"22","author":"Johnson","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2018.12.001_bib19","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2015.63.3511","article-title":"Metformin use and survival of patients with pancreatic cancer: A cautionary lesson","volume":"34","author":"Chaiteerakij","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcjd.2018.12.001_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1499-2671(13)00192-5","volume":"37","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2018.12.001_bib21","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jcjd.2013.01.030","article-title":"Vascular protection in people with diabetes","volume":"37","author":"Stone","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2018.12.001_bib22","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.jcjd.2013.01.037","article-title":"Chronic kidney disease in diabetes","volume":"37","author":"McFarlane","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2018.12.001_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jcjd.2018.12.001_bib24","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.298.22.2634","article-title":"Thiazolidinediones and cardiovascular outcomes in older patients with diabetes","volume":"298","author":"Lipscombe","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2018.12.001_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ede.0000193606.58671.c5","article-title":"Evaluating short-term drug effects using a physician specific prescribing preference as an instrumental variable","volume":"17","author":"Brookhart","year":"2006","journal-title":"Epidemiology"},{"key":"10.1016\/j.jcjd.2018.12.001_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MLR.0b013e318070c08e","article-title":"Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results","volume":"45","author":"Schneeweiss","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.jcjd.2018.12.001_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/pds.4079","article-title":"Confounding of the association between statins and Parkinson disease: Systematic review and meta-analysis","volume":"26","author":"Bykov","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jcjd.2018.12.001_bib28","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2012.46.7043","article-title":"Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes","volume":"31","author":"Margel","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcjd.2018.12.001_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/gme.0b013e318238ff2c","article-title":"Using predictors of hormone therapy use to model the healthy user bias: How does healthy user status influence cognitive effects of hormone therapy?","volume":"19","author":"Gleason","year":"2012","journal-title":"Menopause"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267118300716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267118300716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:33:31Z","timestamp":1761492811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267118300716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1499267118300716"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2018.12.001","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Healthy User Effects With Metformin and Other Oral Antihyperglycemia Medication Users in Adult Patients With Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Canadian Diabetes Association","name":"copyright","label":"Copyright"}]}}